- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01788657
iCBT for Depression - Standard Versus Condensed Treatment Material (KONRAD)
Internet-based Cognitive Behavior Therapy for Depression With Standard Treatment Material Compared to a Condensed Version
Internet-based cognitive behavior therapy (iCBT) has been shown effective for depression in several studies, however the investigators know very little about how the written treatment material should be designed to be effective and at the same time acceptable to the patients. The investigators are not aware of any research that has investigated if slow readers, or persons with difficulty concentrating, can use the standard material or if they would benefit more from using an adapted version.
In this study the investigators will assess reading speed and the ability to concentrate in all patients and then randomise them to an internet-based treatment for depression using either a standard material or a condensed one. The condensed material consists of 30000 words and will be available as text files and on audio files. The standard material consists of 60000 words and is only available as text files. Both groups will have the possibility of e-mail contact with a personal therapist during the treatment.
Patients will be recruited within Örebro County by referrals and self-referrals. The goal is to recruit between 200 and 300 patients during 2 years. The treatment time will be 10 weeks and all patients will be assessed for depression at an interview with a psychologist. There will also be interviews after treatment and one year after treatment. The most important outcome will be depressive symptoms.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Örebro County
-
Örebro, Örebro County, Sweden, 70116
- Örebro County Council
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Fullfill criteria for diagnosis of major depression
- Being able to read and write Swedish
- Have access to the internet
- Being a resident in Örebro county
Exclusion Criteria:
- Severe depressive symptoms (>34 on the MADRS-S)
- High risk for suicide
- Attending cognitive behavior therapy
- Psychosis
- Bipolar disorder
- Addiction to alcohol or illegal drugs
- A somatic or psychiatric condition that is a contraindication for iCBT or in some way debars iCBT, or have to be treated before depression
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Standard internet-based cognitive behavior therapy
Standard internet-based cognitive behavior therapy for depression with a written treatment material consisting of 60000 words (textmaterial only).
|
Introduction to CBT and depression, Behavioral activation, Cognitive restructuring, Improve sleep, Handeling anxiety, Relapse prevention
Other Names:
|
|
Experimental: Condensed internet-based cognitive behavior therapy
Condensed internet-based cognitive behavior therapy for depression with a written treatment material consisting of 30000 words (available as text or audio).
|
Introduction to CBT and depression, Behavioral activation, Cognitive restructuring, Improve sleep, Handeling anxiety, Relapse prevention
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in depressive symptoms at post-treatment and after 12 months
Time Frame: At baseline, after 12 weeks, after 12 months
|
Depressive symptoms will be measured by the self-report measure Montgomery-Åsberg Depression Rating Scale- self-rated.
|
At baseline, after 12 weeks, after 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in diagnostic status for Major depression
Time Frame: Pre-treatment, after 12 weeks and after 1 year
|
The diagnostic status (depression) will be assessed in a face-to-face interview using the structured material Mini-International Neuropsychiatric Interview (M.I.N.I.).
|
Pre-treatment, after 12 weeks and after 1 year
|
|
Change from baseline in symptoms of anxiety
Time Frame: Pre-treatment, after 12 weeks and after 1 year
|
Symptoms of anxiety will be conducted using the self-report measure Beck Anxiety Inventory (BAI)
|
Pre-treatment, after 12 weeks and after 1 year
|
|
Post-treatment treatment satisfaction
Time Frame: After 12 weeks
|
Post-treatment treatment satisfaction will be measured by the self-report measure Client Satisfaction Questionnaire (CSQ)
|
After 12 weeks
|
|
Therapist time
Time Frame: Post treatment
|
Therapist time will be measured automatically by the IT-platform and assesses the time spent on each patient by each therapist.
A mean time will be calculated to report an estimated time needed to treat one patient with the two interventions.
|
Post treatment
|
|
Alcohol use
Time Frame: Pre treatment
|
To assess alkolhol use the AUDIT-questionnaire will be filled out at pre treatment.
|
Pre treatment
|
|
Drug use
Time Frame: Pre treatment
|
To assess drug use the DUDIT-questionnaire will be filled out at pre treatment.
|
Pre treatment
|
|
Treatment satisfaction at follow up
Time Frame: After 1 year
|
Treatment satisfaction at follow up will be measured by the self-report measure Client Satisfaction Questionnaire (CSQ)
|
After 1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reading speed
Time Frame: Pre treatment
|
To assess reading speed the "Diagnostiskt Läs och Skrivprov" (DLS) will be administered during the pre treatment interview.
|
Pre treatment
|
|
Ability to concentrate
Time Frame: Pre treatment
|
To assess the ability to concentrate six items from the WHO adult scale for attention deficit disorder (ASRS-VI.I) will be administered during the pre treatment interview.
|
Pre treatment
|
|
Change from baseline in risk for suicide
Time Frame: After 1,2,3,4,5,6,7,8,9,10,11,12 weeks
|
Change in risk for suicide will be measured by item 9 in the MADRS-S every week
|
After 1,2,3,4,5,6,7,8,9,10,11,12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Fredrik Holländare, PhD, Örebro County Council
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Dnr 63:2012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- ANALYTIC_CODE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depression
-
Johns Hopkins UniversityNot yet recruitingMajor Depression | Major Depression Moderate | Major Depression SevereUnited States
-
Technical University of MunichEnrolling by invitationMajor Depression Moderate | Major Depression SevereGermany
-
Stanford UniversityTerminatedMajor Depressive Disorder | Major Depressive Episode | Major Depressive Disorder, Recurrent | Major Depression Mild | Major Depression Moderate | Major Depression SevereUnited States
-
Cybin IRL LimitedWorldwide Clinical TrialsRecruitingDepression | Major Depressive Disorder (MDD) | Depression - Major Depressive Disorder | Depression in Adults | Depression Disorders | Depression DisorderUnited States, Australia, United Kingdom, Germany, Greece, Poland, Ireland, Czechia
-
Centre Hospitalier Universitaire de BesanconH. Lundbeck A/SCompletedResistant Major DepressionFrance
-
Hawler Medical UniversityCompleted
-
First Affiliated Hospital of Zhejiang UniversityCompleted
-
University of PittsburghCompletedPostpartum Major DepressionUnited States
-
Si TianmeiUnknownMajor Depression DisorderChina
-
The Hong Kong Polytechnic UniversityActive, not recruitingHealthy | Major Depression in RemissionChina
Clinical Trials on Standard internet-based cognitive behavior therapy
-
Stockholm UniversityKarolinska InstitutetCompleted
-
Karolinska InstitutetCompletedAtrial Fibrillation | ArrhythmiaSweden
-
Karolinska InstitutetCompleted
-
Lamar UniversityCompletedTinnitusUnited States
-
Karolinska InstitutetCompleted
-
Karolinska InstitutetRegion StockholmActive, not recruitingGeneralized Anxiety DisorderSweden
-
Karolinska InstitutetCompletedObsessive Compulsive DisorderSweden
-
Karolinska InstitutetRecruitingGeneralized Anxiety Disorder (GAD)Sweden
-
Lamar UniversityCompleted
-
Örebro County CouncilSchool of Law, Psychology and Social Work, Örebro UniversityCompletedBipolar Disorder, Type IISweden